The use of cholinesterase inhibitors in people with Alzheimer's disease has long been a focus of interest and concern. In this podcast, Isabelle Boutron, reports the results of an updated systematic review studying the benefits and harms of one of these agents, rivastigmine, including a novel mode of percutaneous administration

(French version)

Play Now!


Download [mp3] | Read review

This Podcast also available in:

English

Subscribe
To all future Podcasts